USF3 activators are a diverse set of compounds that modulate cellular processes and signaling pathways, which in turn can affect the activity of the USF3 transcription factor. These activators work by targeting various biochemical routes, indirectly influencing the functional state of USF3. The mechanisms by which these chemicals act are varied, encompassing alterations in second messenger levels, modifications of chromatin structure, and changes in the phosphorylation state of proteins. For instance, compounds like forskolin elevate intracellular cAMP, which can activate protein kinase A (PKA), a kinase capable of phosphorylating a broad range of substrates including transcription factors and their associated proteins. This phosphorylation can modify transcription factor activity, potentially affecting USF3 function. Other molecules, such as histone deacetylase inhibitors like sodium butyrate and trichostatin A, alter chromatin architecture, making it more permissive for transcription factor binding and activity, which could indirectly enhance USF3's ability to regulate gene expression.
Furthermore, USF3 activators can also influence transcription factor dynamics through epigenetic modifications. Agents like 5-Aza-2'-deoxycytidine inhibit DNA methyltransferases, leading to the demethylation of DNA and subsequent changes in gene expression profiles. This can affect the binding affinity and regulatory capacity of transcription factors including USF3. Similarly, epigallocatechin gallate (EGCG) targets DNA methyltransferases, potentially affecting gene promoter methylation states and thereby possibly altering USF3 activity. Other activators work by modulating signaling pathways; for example, lithium chloride's inhibition of glycogen synthase kinase-3 (GSK-3) may impact the stability and activity of transcriptional complexes, potentially influencing USF3's role within these complexes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, leading to an increase in cAMP and cGMP levels, which may enhance PKA and PKG activity. This activation can lead to the phosphorylation of transcription factors and enhance USF3's role in transcriptional regulation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit DNA methyltransferases, potentially leading to hypomethylation of gene promoters. This hypomethylation can enhance the accessibility of transcription factors like USF3 to their target DNA sequences, indirectly enhancing USF3's functional activity. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is a histone deacetylase inhibitor which can lead to a more relaxed chromatin state, promoting gene transcription. This can result in enhanced accessibility of USF3 to its target genes, indirectly increasing USF3's functional role in transcriptional activation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol can activate sirtuins, which are involved in deacetylation of histones and transcription factors. This activation can modify the transcriptional activity of several proteins, potentially including USF3, by altering chromatin accessibility and transcription factor binding. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
5-Aza-2'-deoxycytidine is a DNA methyltransferase inhibitor that can lead to DNA demethylation, promoting transcription factor binding to DNA. This may enhance USF3's ability to bind to and activate transcription of its target genes. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is another histone deacetylase inhibitor, which can alter chromatin structure and increase transcription factor access to DNA. By enhancing chromatin accessibility, it could indirectly enhance the functional activity of USF3. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid acts through its receptors to regulate gene expression. While it primarily influences gene transcription, it can also indirectly enhance the activity of other transcription factors, such as USF3, by modulating chromatin structure and transcription factor complexes. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can inhibit NF-κB signaling, which can influence the expression of various genes, including those regulated by transcription factors like USF3. By altering the expression profile of cells, curcumin can indirectly enhance USF3's transcriptional activity. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to GC-rich DNA sequences, inhibiting Sp1 transcription factor binding. This can alter the transcriptional regulation of genes that may be co-regulated by USF3, thereby indirectly affecting USF3's activity. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Beta-Estradiol acts through estrogen receptors which can interact with other transcription factors to regulate gene expression. Such interactions can influence the activity of transcription factors like USF3 by altering coactivator recruitment and chromatin accessibility. | ||||||